Skip to main content

Advertisement

Table 3 Echocardiographic and MRI functional measurements

From: 18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

Echo vs MRI parameters Patient
1 2 3 4 5 6 7 8 9
LV ejection fraction (%)
 Echo 51.4 40.6 67.0 61.0 39.6 65 54.6 51.9 35.0
 MRI 63.0 38.0 50.0 60.0 35.0 59.0 44.0 52.0 26.0
End-diastolic volume (ml)
 Echo 77.4 47.7 66.1 58.0 139.9 N/A N/A 122.7 119.5
 MRI 94.1 86.6 100.0 84.7 140.0 64.6 152.0 132.0 164.0
End-systolic volume (ml)
 Echo 37.6 28.3 21.8 22.6 84.5 N/A N/A 59.1 77.3
 MRI 34.9 53.5 50.1 33.6 90.6 26.5 84.4 64.0 122.0
Time between echocardiogram and 18F-florbetaben PET/MRI 3 d 1 m 3 m 5 d 2 m 6 m 1.5 m 1 m 6 m
  1. N/A not available, d days, m months